New treatment option for Lung Cancer
Official title A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
ClinicalTrials.gov ID: NCT04675476
What this study is testing
- What it's testing
- To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80. Healthy volunteers may be eligible.
You may be able to join if
- 50-80 years old;
- current cigarette smoker or quit within 15 years;
- a 20+ pack-year smoking history;
- non-adherent to lung screening (\>13 months);
- English-speaking;
You likely can't join if
- Individuals with a history of lung cancer
See the full eligibility criteria
- 50-80 years old;
- current cigarette smoker or quit within 15 years;
- a 20+ pack-year smoking history;
- non-adherent to lung screening (\>13 months);
- English-speaking;
- scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and
- able and willing to provide meaningful consent and complete telephone interviews
- Individuals with a history of lung cancer
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.